4.7 Article

Genome-wide RNAi selection identifies a regulator of transmission stage-enriched gene families and cell-type differentiation in Trypanosoma brucei

期刊

PLOS PATHOGENS
卷 13, 期 3, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1006279

关键词

-

资金

  1. Wellcome Trust [103740/Z/14/Z, 095831, 100320/Z/12/Z]
  2. Royal Society [WM140045]

向作者/读者索取更多资源

Trypanosoma brucei, causing African sleeping-sickness, exploits quorum-sensing (QS) to generate the 'stumpy forms' necessary for the parasite's transmission to tsetse-flies. These quiescent cells are generated by differentiation in the bloodstream from proliferative slender forms. Using genome-wide RNAi selection we screened for repressors of transmission stage-enriched mRNAs in slender forms, using the stumpy-elevated ESAG9 transcript as a model. This identified REG9.1, whose RNAi-silencing alleviated ESAG9 repression in slender forms and tsetse-midgut procyclic forms. Interestingly, trypanosome surface protein Family 5 and Family 7 mRNAs were also elevated, which, like ESAG9, are T. brucei specific and stumpy-enriched. We suggest these contribute to the distinct transmission biology and vector tropism of T. brucei from other African trypanosome species. As well as surface family regulation, REG9.1-depletion generated QS-independent development to stumpy forms in vivo, whereas REG9.1 overexpression in bloodstream forms potentiated spontaneous differentiation to procyclic forms in the absence of an external signal. Combined, this identifies REG9.1 as a regulator of developmental cell fate, controlling the expression of Trypanosoma brucei-specific molecules elevated during transmission.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biology

Parasite co-infection: an ecological, molecular and experimental perspective

Frank Venter, Keith R. Matthews, Eleanor Silvester

Summary: Laboratory studies of pathogens often overlook the interactions between pathogens and hosts, despite the fact that hosts frequently sustain co-infections with multiple pathogens. These interactions between co-infecting pathogens and the host immune system are complex and can greatly affect disease outcomes. Researchers have used ecological and experimental studies of trypanosome and malaria infections to examine these interactions.

PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2022)

Review Parasitology

Genome-scale RNAi screens in African trypanosomes

David Horn

Summary: Genome-scale genetic screens have played a crucial role in African trypanosomes by uncovering mechanisms related to drug resistance, metabolism, and gene expression control. They have also been effective in identifying potential antitrypanosomal drug targets.

TRENDS IN PARASITOLOGY (2022)

Article Biochemistry & Molecular Biology

Oligo targeting for profiling drug resistance mutations in the parasitic trypanosomatids

Simone Altmann, Eva Rico, Sandra Carvalho, Melanie Ridgway, Anna Trenaman, Hannah Donnelly, Michele Tinti, Susan Wyllie, David Horn

Summary: This study reports a simple method for rapid and precise editing of priority drug targets in trypanosomatids. By targeting and editing drug targets, combined with sequencing technology, potential impacts on drug efficacy can be assessed quickly.

NUCLEIC ACIDS RESEARCH (2022)

Article Biology

The genomic basis of host and vector specificity in non-pathogenic trypanosomatids

Guy R. Oldrieve, Beatrice Malacart, Javier Lopez-Vidal, Keith R. Matthews

Summary: This study explores the host and vector specificity between Trypanosoma theileri and Trypanosoma melophagium, non-pathogenic parasites of bovines and sheep, respectively. The contrasting genomic features of these species are likely associated with their mode of transmission from their insect vector to their mammalian host.

BIOLOGY OPEN (2022)

Article Microbiology

Control of Variant Surface Glycoprotein Expression by CFB2 in Trypanosoma brucei and Quantitative Proteomic Connections to Translation and Cytokinesis

Gustavo Bravo Ruiz, Michele Tinti, Melanie Ridgway, David Horn

Summary: VSG expression plays a crucial role in parasite virulence and is a fascinating subject in extreme biology. This study identified three candidate VSG regulators and demonstrated the role of CFB2 in controlling VSG expression through the VSG 3' UTR. Additionally, insights into the connections between VSG expression control, ribosomal protein expression, and cytokinesis were revealed.

MSPHERE (2022)

Article Multidisciplinary Sciences

Extracellular release of two peptidases dominates generation of the trypanosome quorum-sensing signal

Mabel Deladem Tettey, Federico Rojas, Keith R. Matthews

Summary: This study identifies secreted peptidases released by trypanosomes and systematically assesses their role in stumpy formation in vivo. The results demonstrate the dominance of oligopeptidase B and metallocarboxypeptidase 1 in quorum sensing.

NATURE COMMUNICATIONS (2022)

Correction Microbiology

Anti-trypanosomatid drug discovery: progress and challenges (vol 5, pg 217, 2017

Manu De Rycker, Susan Wyllie, David Horn, Kevin D. Read, Ian H. Gilbert

NATURE REVIEWS MICROBIOLOGY (2022)

Review Microbiology

Anti-trypanosomatid drug discovery: progress and challenges

Manu De Rycker, Susan Wyllie, David Horn, Kevin D. Read, Ian H. Gilbert

Summary: Leishmaniasis, Chagas disease, and human African trypanosomiasis are major causes of death and illness, particularly in low- and middle-income countries. The development of new medicines for leishmaniasis and Chagas disease is urgently needed, with limited progress in the clinical pipeline for Chagas disease. This review provides an overview of recent advances in understanding the biology of these pathogens, with a focus on drug discovery, as well as the development of new drug candidates and potential solutions to overcome challenges in clinical development.

NATURE REVIEWS MICROBIOLOGY (2023)

Review Parasitology

Distinguishing functions of trypanosomatid protein kinases

Mathieu Cayla, Y. Romina Nievas, Keith R. Matthews, Jeremy C. Mottram

Summary: Trypanosomatid parasitic protozoa have evolved unique mechanisms, such as protein kinases, to regulate their complex life cycles and adapt to different hosts, distinguishing them from other eukaryotes.

TRENDS IN PARASITOLOGY (2022)

Article Multidisciplinary Sciences

Genome-scale RNA interference profiling of Trypanosoma brucei cell cycle progression defects

Catarina A. Marques, Melanie Ridgway, Michele Tinti, Andrew Cassidy, David Horn

Summary: In this study, a genome-wide RNA-interference library screen was used to investigate the cell cycle defects in Trypanosoma brucei. The results provide comprehensive functional genomic evidence for the known and novel machineries, pathways, and regulators that coordinate trypanosome cell cycle progression.

NATURE COMMUNICATIONS (2022)

Article Biology

The SPARC complex defines RNAPII promoters in Trypanosoma brucei

Desislava P. Staneva, Stefan Bresson, Tatsiana Auchynnikava, Christos Spanos, Juri Rappsilber, A. Arockia Jeyaprakash, David Tollervey, Keith R. Matthews, Robin C. Allshire

Summary: This study reveals the unique gene expression regulation mechanism in kinetoplastids, a highly divergent lineage of eukaryotes. The researchers identified a complex called SPARC, which consists of SET27 and CRD1, among other components, that is involved in establishing accurate promoter position and directionality.
Review Immunology

Pathogenicity and virulence of African trypanosomes: From laboratory models to clinically relevant hosts

Liam J. J. Morrison, Pieter C. C. Steketee, Mabel D. D. Tettey, Keith R. R. Matthews

Summary: African trypanosomes are protozoa that are transmitted by vectors and cause significant disease in humans and animals. The severity of infection varies depending on the species of Trypanosoma and the host, making intervention design challenging. This review provides an overview of the current understanding of trypanosome determinants of infection progression and severity, highlighting knowledge gaps and opportunities for developing novel interventions.

VIRULENCE (2023)

Article Microbiology

Competition among variants is predictable and contributes to the antigenic variation dynamics of African trypanosomes

Douglas Escrivani, Viktor Scheidt, Michele Tinti, Joana Faria, David Horn

Summary: Some pathogens use antigenic variation to evade mammalian host adaptive immune responses. African trypanosomes employ variant surface glycoproteins (VSGs) to continually switch their active VSGs and avoid immune recognition. Switched trypanosomes compete in a predictable manner that is dependent on the activated VSG, and the population of cells that activates minichromosome derived VSGs has a competitive advantage.

PLOS PATHOGENS (2023)

Article Microbiology

Genome-wide screens connect HD82 loss-of-function to purine analog resistance in African trypanosomes

Anna Trenaman, Michele Tinti, Abdelmadjid Atrih, David Horn

Summary: Nucleoside analogs are widely used as anti-infective agents, but their potential as anti-parasitic agents has not been fully explored. This study identified two proteins, Tb927.6.2800 and HD82, associated with purine analog resistance in African trypanosomes. The findings also validated two nucleoside kinases involved in pro-drug activation. HD82, related to the mammalian nuclear viral restriction factor SAMHD1, sensitized trypanosomes to nucleoside analogs by reducing native nucleotide pools. This study provides insights into nucleoside/nucleotide metabolism and nucleoside analog resistance in trypanosomatids.

MSPHERE (2023)

Review Microbiology

Anti-trypanosomatid drug discovery: progress and challenges

Manu De Rycker, Susan Wyllie, David Horn, Kevin D. Read, Ian H. Gilbert

Summary: Leishmaniasis, Chagas disease, and human African trypanosomiasis are causing significant death and morbidity, especially in low- and middle-income countries. There is a critical need for new medications for leishmaniasis and Chagas disease, while the clinical development pipeline for Chagas disease remains sparse. This review discusses recent advancements in understanding the biology of these pathogens, with a focus on drug discovery, and explores progress in developing new drug candidates and identifying potential molecular targets. The challenges in developing new clinical candidates are also discussed, along with potential solutions to overcome these hurdles.

NATURE REVIEWS MICROBIOLOGY (2023)

暂无数据